In vitro evaluation of the therapeutic effectiveness of EBV-LMP2 recombinant adenovirus vaccine in nasopharyngeal carcinoma.
Biomed Pharmacother
; 121: 109626, 2020 Jan.
Article
in En
| MEDLINE
| ID: mdl-31743878
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Viral Matrix Proteins
/
Adenovirus Vaccines
/
Nasopharyngeal Carcinoma
Limits:
Animals
Language:
En
Journal:
Biomed Pharmacother
Year:
2020
Document type:
Article
Affiliation country:
China
Country of publication:
France